The activation of the IL-6/JAK/STAT3 signaling pathway can inhibit the function of immune cells in the tumor microenvironment, and inhibition of the IL-6/JAK/STAT3 signaling pathway can inhibit the growth of tumor cells and alleviate the immunosuppression in the tumor microenvironment [38]. This evidence concerns the gene STAT3 and neoplasm.